Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|5|3|382-391

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.5, Iss.3, 2012-11, pp. : 382-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategies in CNS metastases

By Kosmas Christos   Tsakonas George   Mylonakis Nikolaos  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2087-2098

Informa Healthcare

Access to resources Recommend Favorite

Treatment of HIV infection - the road travelled and the journey ahead

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Update on bevacizumab and other angiogenesis inhibitors for brain cancer

By Rinne Mikael L   Lee Eudocia Q   Nayak Lakshmi   Norden Andrew D   Beroukhim Rameen   Wen Patrick Y   Reardon David A  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 137-153

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

By Tomao Federica   Papa Anselmo   Rossi Luigi   Caruso Davide   Zoratto Federica   Benedetti Panici Pierluigi   Tomao Silverio  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite